TriLink BioTechnologies庐 Expands Capabilities with Launch of 鈥楢nalytical Sciences Center of Excellence鈥�
SAN DIEGO--(BUSINESS WIRE)--Nov 2, 2023--<a ...
SAN DIEGO--(BUSINESS WIRE)--Nov 2, 2023--<a ...
GALWAY, Ireland--(BUSINESS WIRE)--Nov 2, 2023--<a ...
MCLEAN, Va.--(BUSINESS WIRE)--Nov 1, 2023--<a ...
WALTHAM, Mass.--(BUSINESS WIRE)--Nov 1, 2023--<a ...
BRANFORD, Conn.--(BUSINESS WIRE)--Nov 1, 2023--<a ...
TORONTO--(BUSINESS WIRE)--Nov 1, 2023--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage biotechnology company leveraging its hydrogen sulfide platform to develop next-generation therapies targeting pain and inflammation, is pleased to announce the completion of the ...